An innovative study reveals that administering immunotherapy before 3 p.m. dramatically improves survival in lung cancer patients. The finding highlights how the circadian rhythm influences the immune system’s response to drugs.
An innovative study reveals that administering immunotherapy before 3 p.m. dramatically improves survival in lung cancer patients. The finding highlights how the circadian rhythm influences the immune system’s response to drugs.